Meeting description: We updated the Member on the implementation of the agreement with National Health Service Scotland providing access to treatments for people with cystic fibrosis in Scotland. We provided a briefing on Vertexas approach to innovation. We specifically raised the development of potential cell and genetic therapies and highlighted the policy and system implications arising. We also discussed Scotlandas life sciences ecosystem including advanced manufacturing capacity.
Topic label: Health